Patient | Age | Gender | Clinical features3-150 | Family history |
1 | 47 | M | HL, DM, HA | HL |
2 | 45 | F | HL, HA, PS, CD | HL |
3 | 43 | M | DM, MI | DM |
4 | 31 | M | CM, EP, HA, PS, CD | DM |
5 | 42 | F | MI | MI |
6 | 45 | M | MI | |
7 | 42 | F | HL | HL |
8 | 48 | M | HL | HL |
9 | 43 | F | PD | |
10 | 66 | F | Non-AD | |
11 | 88 | F | AD | |
12 | 80 | F | AD, DM, HL | |
13 | 56 | M | AD, DM | DM |
AD, Alzheimer's disease; CD, cognitive decline; CM, cardiomyopathy; DM, diabetes mellitus; EP, epilepsy; HA, headache; HL, hearing loss; MI, migraine; non-AD, non-Alzheimer type dementia; PD, Parkinson's disease; PS, psychiatric symptoms.
↵3-150 The phenotype that led to the identification of the proband is mentioned as the first clinical feature.